Home > Compound List > Product Information
Methyl indole-3-carboxylate_Molecular_structure_CAS_942-24-5)
Click picture or here to close

Methyl indole-3-carboxylate

Catalog No. 395307 Name Sigma Aldrich
CAS Number 942-24-5 Website http://www.sigmaaldrich.com
M. F. C10H9NO2 Telephone 1-800-521-8956
M. W. 175.18396 Fax
Purity 99% Email
Storage Chembase ID: 7885

SYNONYMS

Title
吲哚-3-甲酸甲酯
IUPAC name
methyl 1H-indole-3-carboxylate
IUPAC Traditional name
methyl 1H-indole-3-carboxylate
Synonyms
3-Carbomethoxyindole
3-Methoxycarbonylindole
Methyl indolyl-3-carboxylate

DATABASE IDS

CAS Number 942-24-5
PubChem SID 24864651
MDL Number MFCD00189407

PROPERTIES

Empirical Formula (Hill Notation) C10H9NO2
Purity 99%
Melting Point 149-152 °C(lit.)
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H315-H319-H335
European Hazard Symbols Irritant Irritant (Xi)
MSDS Link Download
Personal Protective Equipment dust mask type N95 (US), Eyeshields, Gloves
GHS Precautionary statements P261-P305 + P351 + P338
Risk Statements 36/37/38
Safety Statements 26-36
German water hazard class 3

DETAILS

Description (English)
Packaging
25, 100 g in glass bottle
Application
Reactant for preparation of:
• Nitric oxide synthase (nNOS) inhibitorS1
• Protein kinase c alpha (PKCα) inhibitors2
• Inhibitors of the C-terminal domain of RNA polymerase II as antitumor agents
• Kinase insert domain receptor (KDR) inhibitors3
• Organocatalysts for the anti-Mannich reaction4
• Very late antigen-4 (VLA-4) antagonists5
• Inhibitors of Human 5-Lipoxygenase6
• Serotonin 5-HT4 receptor antagonists7
• Hyaluronidase inhibitors8Reactant for:
• Enantioselective Meerwein-Eschenmoser Claisen rearrangement reactions†
Description (简体中文)
包装
25, 100 g in glass bottle
Application
Reactant for preparation of:
• Nitric oxide synthase (nNOS) inhibitorS1
• Protein kinase c alpha (PKCα) inhibitors2
• Inhibitors of the C-terminal domain of RNA polymerase II as antitumor agents
• Kinase insert domain receptor (KDR) inhibitors3
• Organocatalysts for the anti-Mannich reaction4
• Very late antigen-4 (VLA-4) antagonists5
• Inhibitors of Human 5-Lipoxygenase6
• Serotonin 5-HT4 receptor antagonists7
• Hyaluronidase inhibitors8Reactant for:
• Enantioselective Meerwein-Eschenmoser Claisen rearrangement reactions†

REFERENCES